HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 296/2/C285    most recent 00418.2008v2 00418.2008v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Klein, H. Articles by Sauvé, R. Search for Related Content PubMed PubMed Citation Articles by Klein, H. Articles by Sauvé, R.

MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS

Inhibition of the KCa3.1 channels by AMP-activated protein kinase in human airway epithelial cells

Groupe d'étude sur les protéines membranaires, Département de physiologie¹ and ²Département de médecine, Université de Montréal; ³Centre de recherche, (CR-CHUM)-Hôtel-Dieu Montréal, Quebec, Canada; and ⁴INSERM U866, Lipides-nutrition-cancer, Faculté de Médecine, Dijon 21079, France

Submitted 12 August 2008 ; accepted in final form 1 December 2008

The vectorial transport of ions and water across epithelial cells depends to a large extent on the coordination of the apical and basolateral ion fluxes with energy supply. In this work we provide the first evidence for a regulation by the 5'-AMP-activated protein kinase (AMPK) of the calcium-activated potassium channel KCa3.1 expressed at the basolateral membrane of a large variety of epithelial cells. Inside-out patch-clamp experiments performed on human embryonic kidney (HEK) cells stably transfected with KCa3.1 first revealed a decrease in KCa3.1 activity following the internal addition of AMP at a fixed ATP concentration. This effect was dose dependent with half inhibition at 140 µM AMP in 1 mM ATP. Evidence for an interaction between the COOH-terminal region of KCa3.1 and the 1-subunit of AMPK was next obtained by two-hybrid screening and pull-down experiments. Our two-hybrid analysis confirmed in addition that the amino acids extending from Asp³⁸⁰ to Ala⁴⁰⁰ in COOH-terminal were essential for the interaction AMPK-1/KCa3.1. Inside-out experiments on cells coexpressing KCa3.1 with the dominant negative AMPK-1-R299G mutant showed a reduced sensitivity of KCa3.1 to AMP, arguing for a functional link between KCa3.1 and the 1-subunit of AMPK. More importantly, coimmunoprecipitation experiments carried out on bronchial epithelial NuLi cells provided direct evidence for the formation of a KCa3.1/AMPK-1 complex at endogenous AMPK and KCa3.1 expression levels. Finally, treating NuLi monolayers with the membrane permeant AMPK activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) caused a significant decrease of the KCa3.1-mediated short-circuit currents, an effect reversible by coincubation with the AMPK inhibitor Compound C. These observations argue for a regulation of KCa3.1 by AMPK in a functional epithelium through protein/protein interactions involving the 1-subunit of AMPK.

potassium channel; protein-protein interactions; cystic fibrosis

This article has been cited by other articles:

				G. R. Steinberg and B. E. Kemp AMPK in Health and Disease Physiol Rev, July 1, 2009; 89(3): 1025 - 1078. [Abstract] [Full Text] [PDF]